Series A - Histogenics
Investment Firm
Overview
Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.
Announced Date
Aug 11, 2006
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Stryker |
Round Details and Background
Histogenics raised $13100000 on 2006-08-11 in Series A
Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 02, 2014 |  Post-IPO Equity - Histogenics | 3 | - | 70.0M |
| Jul 23, 2012 | Series A - Histogenics | 8 | - | 49.0M |
| May 27, 2011 | Debt Financing - Histogenics | - | 34.3M | |
| Sep 04, 2008 | Series B - Histogenics | 2 | - | 13.1M |
Recent Activity
There is no recent news or activity for this profile.